485 related articles for article (PubMed ID: 2928550)
1. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging.
Unger EC; Winokur T; MacDougall P; Rosenblum J; Clair M; Gatenby R; Tilcock C
Radiology; 1989 Apr; 171(1):81-5. PubMed ID: 2928550
[TBL] [Abstract][Full Text] [Related]
2. Liposomal Gd-DTPA: preparation and characterization of relaxivity.
Tilcock C; Unger E; Cullis P; MacDougall P
Radiology; 1989 Apr; 171(1):77-80. PubMed ID: 2928549
[TBL] [Abstract][Full Text] [Related]
3. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
[TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA as a contrast agent in CT.
Bloem JL; Wondergem J
Radiology; 1989 May; 171(2):578-9. PubMed ID: 2704827
[TBL] [Abstract][Full Text] [Related]
6. Liposomal Gd-DTPA: effect of encapsulation on enhancement of hepatoma model by MRI.
Unger EC; MacDougall P; Cullis P; Tilcock C
Magn Reson Imaging; 1989; 7(4):417-23. PubMed ID: 2811620
[TBL] [Abstract][Full Text] [Related]
7. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
8. MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR; Press GA
Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
Reimer P; Rummeny EJ; Shamsi K; Balzer T; Daldrup HE; Tombach B; Hesse T; Berns T; Peters PE
Radiology; 1996 Apr; 199(1):177-83. PubMed ID: 8633143
[TBL] [Abstract][Full Text] [Related]
12. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization.
Ogan MD; Schmiedl U; Moseley ME; Grodd W; Paajanen H; Brasch RC
Invest Radiol; 1987 Aug; 22(8):665-71. PubMed ID: 3667174
[TBL] [Abstract][Full Text] [Related]
13. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
[TBL] [Abstract][Full Text] [Related]
15. Multicenter double-blind placebo-controlled study of gadopentetate dimeglumine as an MR contrast agent: evaluation in patients with cerebral lesions.
Russell EJ; Schaible TF; Dillon W; Drayer B; LiPuma J; Mancuso A; Maravilla K; Goldstein HA
AJR Am J Roentgenol; 1989 Apr; 152(4):813-23. PubMed ID: 2646872
[TBL] [Abstract][Full Text] [Related]
16. Calvarial and skull base metastases: comparison of nonenhanced and Gd-DTPA-enhanced MR images.
West MS; Russell EJ; Breit R; Sze G; Kim KS
Radiology; 1990 Jan; 174(1):85-91. PubMed ID: 2294576
[TBL] [Abstract][Full Text] [Related]
17. Pyogenic liver abscess: contrast-enhanced MR imaging in rats.
Weissleder R; Saini S; Stark DD; Elizondo G; Compton C; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1988 Jan; 150(1):115-20. PubMed ID: 3257107
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of Gd-DTPA-enhanced MR imaging of benign extraaxial tumors.
Haughton VM; Rimm AA; Czervionke LF; Breger RK; Fisher ME; Papke RA; Hendrix LE; Strother CM; Turski PA; Williams AL
Radiology; 1988 Mar; 166(3):829-33. PubMed ID: 3340779
[TBL] [Abstract][Full Text] [Related]
19. Liver. III: Gadolinium-based hepatobiliary contrast agents (Gd-EOB-DTPA and Gd-BOPTA/Dimeg).
Giovagnoni A; Paci E
Magn Reson Imaging Clin N Am; 1996 Feb; 4(1):61-72. PubMed ID: 8673717
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging.
Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S
Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]